New Product For The Removal Of Endotoxins - profos ag Extended The EndoTrap Product Portfolio
10/19/2005 5:09:48 PM
REGENSBURG, Germany--(BUSINESS WIRE)--May 25, 2005--The German biotech company profos ag offers optimal solutions for the high efficient removal of toxic contaminations derived from bacteria, so-called endotoxins, from biopharmaceutical products. With the launch of "EndoTrap red" the profos ag extends their EndoTrap product portfolio.
In recent years biopharmaceuticals have been playing more and more a major role for the treatment of diseases like diabetes, myocardial infarction, cancer or AIDS. These biopharmaceuticals are purified from naturally occurring or genetically modified organisms like bacteria, cell-cultures or even plants. Endotoxins are a general threat for every biomanufacturing process. Highest purity is needed to guarantee optimal efficacy of the bio-medication and reduction of unwanted side effects. Therefore the bio-pharma industry makes greatest effort to detect the endotoxin concentration and to remove these endotoxins from their products.
comments powered by